Upfront HIPEC May Up Survival in Ovarian Cancer

(MedPage Today) -- Patients with newly diagnosed ovarian cancer lived almost 16 months longer if they received heated intraperitoneal chemotherapy (HIPEC) after surgery, a large retrospective study from China showed.
Median overall survival (OS...

Source link

Related posts

Afib Ablation Sans Surgical Backup Said to be OK, But Doubts Linger


Should I Get Clavicle Lengthening Over Deltoid Implants?


Does 'Obesity Paradox' Hold in the ICU?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy